chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient developed 3cm red, indurated area at injection site within 24hrs of administration of Td. Area increased in size to 5cm and pain within 48hrs of administration. Also ran intermittant low grade fever of 99.5 F for 3-4 days. Treated with cephalexin 500mg PO QID for 5 days, loratadine 10mg QD, ibuprofen and icing PRN. She never developed hives, rash or respiratory symptoms. Fever, redness and pain resolved and induration was decreased to 1.5cm by 72 hours post administration.
High fever (102-103 degrees F), tiredness. Since it is now 6+ months since the reaction, I don't remember whether there were other symptoms such as muscle aches. Sorry!
Felt sore and pain moving  left arm after second shot August 13th 2021.  Thought it would go away within a week.  Went to see the doctor a month later when I had limited motion and extreme pain of the left arm when doing daily activities such as washing hair and getting dressed.  Doctor prescribed a week of steroids and going to Physical Therapy.
Arm swollen (left) and red after tetanus shot; 43mm X 41mm (red, hot and swollen).
Chills; Fever; Body aches particularly in my back and hips; Body aches particularly in my back and hips; Headache; Lethargy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Apr2022 as dose 3 (booster), single (Lot number: FL3197) at the age of 55 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing); "Known allergies: Contrast dye" (unspecified if ongoing); "Covid-19" (unspecified if ongoing), notes: If covid prior vaccination: Yes. Concomitant medication(s) included: METOPROLOL SUCCINATE; ESCITALOPRAM; ATORVASTATIN. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EN6203), administration date: 23Mar2021, when the patient was 54-year-old, for Covid-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EN6203), administration date: 01Mar2021, when the patient was 54-year-old, for Covid-19 immunization. The following information was reported: ARTHRALGIA (non-serious), BACK PAIN (non-serious) all with onset 21Apr2022, outcome "recovered" (2022) and all described as "Body aches particularly in my back and hips"; CHILLS (non-serious) with onset 21Apr2022, outcome "recovered" (2022); PYREXIA (non-serious) with onset 21Apr2022, outcome "recovered" (2022), described as "Fever"; HEADACHE (non-serious) with onset 21Apr2022, outcome "recovered" (2022); LETHARGY (non-serious) with onset 21Apr2022, outcome "recovered" (2022). Therapeutic measures were not taken as a result of chills, pyrexia, arthralgia, back pain, headache, lethargy.  Additional information: The patient did not receive any other vaccine with in 4 weeks of covid-19 vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Influenza type B. Chills, sneezing, runny nose, body aches.
12/1 - Extreme fatigue, muscle aches and weakness 12/2 - onset of swelling under arm, across left side of chest and back 12/3 - severe swelling and pain under armpit, across left side of chest and upper back.  Inability to raise left arm fully above head.  Numbness from left elbow down arm and to tip of left pinky.  Numbness on left side of face from ear, across cheek and down to jawline.  Continued fatigue.  Onset of cold like symptoms as well.   12/4 - some reduction in swelling, but still painful.  Less numbness in face 12/5 - facial numbness gone, swelling is still reducing and some pain remains 12/6 - still some swelling, particularly in left pectoral area, mild aches in left arm, continued fatigue
Vaccination adverse reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported No treatment medications were reported  Amendment version created on 25-Aug-2021, to correct Initial Receipt Date from 16-Jul-2020 to 16-Jul-2021.
One day post vax of an inadvertently intradermal injection of TD vaccine in the forearm, pt developed an injection site reaction characterized by redness, swelling and pain the next day. Pt recovered.
He received his booster vaccine on 12Oct2021; arm at the injection site down deep is sore and it has remained sore; a problem with lifting his left arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Oct2021 (Lot number: FE3590) at the age of 72 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 01, EN5318), administration date: 30Jan2021, when the patient was 71 years old, for Covid-19 immunization, reaction(s): "None"; Bnt162b2 (Dose: 02, Lot: EN6201), administration date: 21Feb2021, when the patient was 71 years old, for Covid-19 immunization, reaction(s): "None". The following information was reported: IMMUNISATION (non-serious) with onset 12Oct2021, outcome "unknown", described as "He received his booster vaccine on 12Oct2021"; VACCINATION SITE PAIN (non-serious) with onset 12Oct2021, outcome "not recovered", described as "arm at the injection site down deep is sore and it has remained sore"; LIMB DISCOMFORT (non-serious) with onset 12Oct2021, outcome "not recovered", described as "a problem with lifting his left arm". Therapeutic measures were taken as a result of vaccination site pain, limb discomfort.  Additional information: History of previous immunization with the Pfizer vaccine considered as suspect included Pfizer Covid Vaccines. No additional vaccines administered on same date of the Pfizer suspect. Adverse event did not require a visit to Emergency Room/Physician Office. No vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine. No Adverse events following prior vaccinations. No relevant medical history (including any illness at time of vaccination). No relevant family medical history to adverse event. No relevant tests done. Time the Vaccination Was Given: Afternoon 15:00-16:00. Treatment included Tylenol.  Follow-up attempts are completed. No further information is expected.
Patient received his first dose of Pfizer COVID vaccine on 3/29/21. On 4/9/21, patient developed confusion, dysarthria, shakiness, and falls at home. Patient was brought to the ER by his family on 4/11/21 and was admitted to the hospital. Patient was found to be COVID positive in the ER and had low O2 saturation (83% on room air). Supplemental oxygen and COVID treatment were started and patient was admitted to the ICU on 4/11. Patient was later transferred to a medical floor on the evening of 4/12.
45 min after vaccination my faced turned red and felt very warm. The right sight of my face felt very tight  and the right corner of my lip felt numb. The symptoms went away 1.5-2 hrs after they started
Redness/warmth/swelling at the site. Flu like sxs, body aches, fever. Got AUGMENTIN from NP.
her whole arm blew up, it wrapped around her arm and looked like cellulitis; she was tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired). At the time of the report, PERIPHERAL SWELLING (her whole arm blew up, it wrapped around her arm and looked like cellulitis) and FATIGUE (she was tired) outcome was unknown.            No concomitant medication was provided by reporter.  The second shot, her whole arm blew up, it wrapped around her arm and looked like cellulitis. That was okay, she was tired and had normal stuff after get the vaccine.   No treatment drug was provided by reporter.   This case was linked to MOD-2022-456142, MOD-2022-452516 (Patient Link).
Pt present in office on 2/4/08 with rash that had started 2 days prior.
24 hours of fever, fussiness, decreased appetite, 8 hours of papular/pustules type rash.
This spontaneous report as received from a registered nurse refers to unspecified patients of unknown age. On unspecified dates, the patients were vaccinated with (Oka-Merck) PROQUAD which was exposed to unknown temperatures out of the recommended range for an unknown period of time (dose, route, lot number and expiration date unknown). No adverse effect had been reported. All telephone attempts to obtain follow-up information have been unsuccessful. Follow up information has been received from a physician and a licensed practical nurse (LPN) regarding a 4 year old (also reported as age 5, units not provided) female patient (child). On 28-JUL-2014 2:36 pm, the patient might have been immunized with a dose of  (Oka-Merck) PROQUAD lot number K007158, expiration date 12-NOV-2015, in the right thigh (dose number, route and dose were not reported) which was not stored at the inappropriate temperature (not further specified). Concomitant medications were not specified. The outcome of the event was reported as unknown. This is one of several reports received from the same source. Additional information is not expected because follow up has been obtained.
felt a lot of liquid falling out of her arm while being vaccinated; felt a lot of liquid falling out of her arm while being vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (felt a lot of liquid falling out of her arm while being vaccinated) and SYRINGE ISSUE (felt a lot of liquid falling out of her arm while being vaccinated) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced UNDERDOSE (felt a lot of liquid falling out of her arm while being vaccinated) and SYRINGE ISSUE (felt a lot of liquid falling out of her arm while being vaccinated). At the time of the report, UNDERDOSE (felt a lot of liquid falling out of her arm while being vaccinated) and SYRINGE ISSUE (felt a lot of liquid falling out of her arm while being vaccinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.
"got sick" after each dose; experienced side effects after each dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS ("got sick" after each dose) and VACCINATION COMPLICATION (experienced side effects after each dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Previously administered products included for Flu: Seasonal Flu vaccine (Intramuscular) in October 2021. Past adverse reactions to the above products included No adverse event with Seasonal Flu vaccine. Concurrent medical conditions included Sulfonamide allergy, Allergic reaction to bee sting and High cholesterol. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced ILLNESS ("got sick" after each dose) and VACCINATION COMPLICATION (experienced side effects after each dose). At the time of the report, ILLNESS ("got sick" after each dose) and VACCINATION COMPLICATION (experienced side effects after each dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medications were reported.   Patient received the second dose after the first dose , followed by two booster doses. Symptoms resolved in 2 days.   This case was linked to MOD-2022-537585, MOD-2022-537584, MOD-2022-537582 (Patient Link).
Patient admitted to hospital on 5/14, found to have acute myocarditis. For viral cause, but given this occurred after vaccination, want to report.
Overall skin is now darker; bruise at injection site; arm pain in other arm after pain in injection arm subsided; fatigue; arm of injection pain; fever; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (Overall skin is now darker), VACCINATION SITE BRUISING (bruise at injection site), PAIN IN EXTREMITY (arm pain in other arm after pain in injection arm subsided), FATIGUE (fatigue) and VACCINATION SITE PAIN (arm of injection pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product INFLUENZA VACCINE INACT SPLIT 4V (QUADRIVALENT INFLUENZA VACCINE) for an unknown indication.    Previously administered products included for COVID-19 vaccination: PFIZER BIONTECH COVID-19 VACCINE (First dose) in April 2021 and PFIZER BIONTECH COVID-19 VACCINE (Second dose) in May 2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.   On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE INACT SPLIT 4V (QUADRIVALENT INFLUENZA VACCINE) (unknown route) 1 dosage form. In December 2021, the patient experienced SKIN DISCOLOURATION (Overall skin is now darker), VACCINATION SITE BRUISING (bruise at injection site), PAIN IN EXTREMITY (arm pain in other arm after pain in injection arm subsided), FATIGUE (fatigue), VACCINATION SITE PAIN (arm of injection pain) and PYREXIA (fever). At the time of the report, SKIN DISCOLOURATION (Overall skin is now darker), VACCINATION SITE BRUISING (bruise at injection site) and PAIN IN EXTREMITY (arm pain in other arm after pain in injection arm subsided) had not resolved, FATIGUE (fatigue) and VACCINATION SITE PAIN (arm of injection pain) was resolving and PYREXIA (fever) had resolved.            Concomitant medications were not reported. Treatment medications were not reported.   This case was linked to MOD-2021-423636 (Patient Link).
No additional AE details/ What was the patient's response?: None; temp excursion/ TE evaluation states vaccines have been administered; This spontaneous report as received from a certified medial assistant refers to a 6-year-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. The patient did not have any illness at the time of vaccination.  On 23-MAR-2022, a virus vaccine live (oka/merck) (VARIVAX), lot # U025790, expiry date 19-AUG-2023, experienced a temperature excursions of -14 degrees Celsius (C) up to -10 degrees C for 3 hours, and -10 degrees C up to 8 degrees C for 1 hours 30 minutes. There was not previous excursion.  On 25-APR-2022, the patient was vaccinated by a healthcare professional at the private doctor's office/hospital with the second dose of varicella virus vaccine live (oka/merck) (VARIVAX), which experienced above mentioned temperature excursion (product storage error), lot # and expiry date as above, subcutaneously (SQ) for prophylaxis. It was reported that there was no patient's response. No additional adverse event details were reported (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2204USA009330: US-009507513-2205USA008051: US-009507513-2205USA008004: US-009507513-2205USA007852: US-009507513-2205USA007821:
I had upper abdominal pain (left quadrant pain). I went to the ER, in which they did a CAT scan. I could not take a deep breath.  They determined from the CAT scan that a perforated colon.  I had loss of appetite. I was in the hospital for 3 days with antibiotic and IV transfusion.
trouble hearing out of the right ear for probably 3 weeks; increased head ache; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (trouble hearing out of the right ear for probably 3 weeks) and HEADACHE (increased head ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 076C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HYPOACUSIS (trouble hearing out of the right ear for probably 3 weeks) and HEADACHE (increased head ache). At the time of the report, HYPOACUSIS (trouble hearing out of the right ear for probably 3 weeks) and HEADACHE (increased head ache) had resolved.            concomitant medications were provided. No treatment medications were provided.
My thing was like if you feel cold, if you have a cold; My thing was like if you feel cold, if you have a cold; I feel my shoulder stiff or something; This is a spontaneous report from a contactable consumer or other non HCP (patient). This is the second case out of the 2 cases. A female patient of an unspecified age received bnt162b2 (BNT162B2, formulation; solution for injection), dose 2 via an unspecified route of administration on 29Apr2021 (Batch/Lot Number: EW0169) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medication was not reported. Historical vaccine included BNT162B2 first dose (Batch/Lot number; EW0162) for Covid-19 immunization. The patient stated "It was not like a serious. I din't have fever, nothing but just mine was okay, it was minor, I felt my shoulder stiff or something, maybe it was nothing to do with this". The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
himself is dealing with some mental illness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), on 23May2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose:2, unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose:1, unknown manufacturer), for COVID-19 Immunization. The following information was reported: MENTAL DISORDER (non-serious), outcome "unknown", described as "himself is dealing with some mental illness".  Additional information: Customer asked, so how can he see his results, customer confirmed that it was for his covid test result. Response was apologized and advised the caller that Pfizer does not have access to individual patients covid test result. Referred to medical facility where his covid test was taken. Consumer wanted to know if there would be some changes if his wife will not be getting the Pfizer BioNTech COVID-19 Vaccine booster dose (third shot). Yesterday, patient went and got a shot, it's his third one now. Patient was trying to see his results but they're not ready. But patient have been taking shots, himself and his wife together, every shot his wife took, he took,  they took it together. Now, he took one and patients wife says she is not taking another one. He mean is it possible that it's supposed to keep on going the same way it's been going. Because if they changed it, he gotta change then, right. This is serious, if patient got the shot, you need to get it again, not no problem, there's gonna be some change, real change. His wife don't want to take the other one (exact words were not clear during the recording, could be referring to the third shot of the Pfizer BioNTech COVID-19 Vaccine) but she's been taking the other one since (exact word was not clear during the recording) and she's younger than he was, but she should take it too, right. He was telling his wife, we've been taking the shot since we've been together and now she don't want to take the last one, are not she supposed to. Yeah, that's it and she got three. Therefore, she is gonna be different there too, because if she was with me, she won't take them there. She gonna have. This is gonna be a change right here, this is where the change coming at now. Caller's wife only took 2 shots of the Pfizer BioNTech COVID-19 vaccine and the last shot is last year (month was not disclosed by the caller). Caller also mentioned that he himself is dealing with some mental illness. Unable to obtain age information for caller. Offered to warm transfer to agent however caller stated that he doesn't want to talk about it when probed for more safety information.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I developed Bell's Palsy. paralyzed left side, loss of taste on the left side. I have been real tired. Prescribed prednisone.